Valneva to Participate at U.S. and European Investor Conferences in June

In This Article:

VALNEVA
VALNEVA

Saint-Herblain (France), May 26, 2025Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor conferences in the United States and Europe in June 2025.

Key topics for discussion include Valneva’s commercial stage vaccines and its differentiated portfolio of vaccine candidates, including VLA15, the world’s leading Lyme disease vaccine candidate. VLA15 is partnered with Pfizer and currently being evaluated in a pivotal Phase 3 trial for which the Company expects first data at the end of 2025.

Institutional investors who would like to meet 1on1 with management at any of the below conferences are asked to submit a request to their representative at the respective bank.

Jefferies Global Healthcare Conference

Format                 Fireside chat and investor meetings
Date/ time                 June 5, 2025, 11:40am ET
Webcast        Link. A replay of the webcast will also be available in the “Investor” section of the Valneva website.
Location                New York

Goldman Sachs 46th Annual Global Healthcare Conference:

Format                        Fireside chat and investor meetings
Date/ time                June 9, 2025, 1:20pm ET
Location                 Miami, FL

Oddo BHF Nextcap Forum:

Format                        Investor meetings only
Date/ time                June 12, 2025
Location                 Virtual

BNP Paribas SMID Cap Conference:

Format                        Investor meetings only
Date/ time                June 18, 2025
Location                 Paris, France